JHSM
Journal of Health Sciences and Medicine

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

ISSN: Active
eISSN: 2636-8579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
The utility of apparent diffusion coefficient values in predicting liver fibrosis in chronic hepatitis B
Abstract
Aims: We aimed to determine the relationship between apparent diffusion coefficient (ADC) values obtained from diffusion-weighted images, histopathological fibrosis, and activity stages in patients with chronic hepatitis B infection. Material and
Methods: A total of 30 patients with chronic hepatitis B admitted to our hospital between September 2012 and June 2014 were included in the study. All patients underwent biopsy and abdomen MRI examination before the treatment. Diffusion examinations at five different b-values (50, 300, 500, 700, and 1000 s/mm2) were added to the abdominal MRI examination.
Results: The hepatic ADC values at all b-values were negatively correlated with fibrosis stages (p<0.001 for all b-values). The ADC values at b-values 300 and 1000 were significantly lower in patient groups with histological activity indices 1 and higher compared to the patient group whose activity index was 0 (at b-value 300 p<0.034, and at b-value 1000 p<0.027). The ADC values at b-values 50, 500 and 700 were not significantly in patient groups with histological activity indices 1 and higher compared to the patient group whose activity index was 0. Hepatic ADC was a significant predictor of stage 2 or greater and stage 3 or greater fibrosis, with sensitivity of 81%-100% and 81%-96% , and specificity of 84,2%-100% and 100% (ADC with all b values).
Conclusion: The ADC values have high sensitivity and specificity in indicating liver fibrosis in chronic hepatitis B infection. We suggest that the addition of diffusion-weighted MR images into liver MRI examination might reduce the requirement for liver biopsies in patients with chronic hepatitis B.

Keywords : Apparent diffusion coefficient, diffusion MRI, hepatitis B, fibrosis, liver, histological activity index

Download Article


1. Zeng MD, Lu LG, Mao YM, et al. Prediction of significantfibrosis in HBeAg-positive patients with chronic hepatitis B bya noninvasive model. Hepatology 2005; 42: 1437- 45.
2. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concisereview. Am J Gastroenterol 2004; 99: 1160-74.
3. Taouli B, Tolia AJ, Losada M, et al. Diffusion weighted MRIfor quantification of liver fibrosis: preliminary experience. AJR2007; 189: 799-806
4. Taouli B, Koh DM. Diffusion-weighted MR imaging of theliver. Radiology 2010; 254: 47-66.
5. The French METAVIR Cooperative Study Group. Intraobserverand interobserver variations in liver biopsy interpretion inpatients with chronic hepatitis c. Hepatology 1994; 20: 15-20
6. Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis.Hepatology 2006; 43:113-20
7. Rockey DC. Current and future anti-fibrotic therapies forchronic liver disease. Clin Liver Dis 2008; 12: 939-62.
8. Başar O, Yimaz B, Ekiz F, et al. Non-invasive tests in predictionof liver fibrosis in chronic hepatitis B and comparison withpost-antiviral treatment results. Clin Res Hepatol Gastroenterol2013; 37: 152-8.
9. Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K,Matsumoto T. Cirrhosis: modified caudate-right lobe ratio.Radiology 2002; 224: 769-74.
10. Manning DS, Afdhal NH. Diagnosis and quantitation offibrosis. Gastroenterology 2008; 134: 1670-81.
11. Fujimoto K, Tonan T, Azuma S, et al. Evaluation of the meanand entropy ofapparent diffusion coefficient values in chronichepatitis C: correlation with pathologic fibrosis stage andinflammatory activity grade. Radiology 2011; 258: 739-48.
12. Vaziri-Bozorg SM, Ghasemi-Esfe AR, Khalilzadeh O, et al.Diffusion-weighted magnetic resonance imaging for diagnosisof liver fibrosis and inflammation in chronic viral hepatitis: theperformance of low or high B values and small or large regionsof interest. Can Assoc Radiol J 2012; 63: 304-11.
13. Boulanger Y, Amara M, Lepanto L, et al. Diffusion-weightedMR imaging of the liver of hepatitis C patients. NMR Biomed2003; 16: 132-6.
14. Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P,Van Beers BE. Assessment of diffusion-weighted MR imagingin liver fibrosis. J Magn Reson Imaging 2007; 25: 122-8.
15. Lewin M, Poujol-Robert A, Bo&euml;lle PY, et al. Diffusion-weightedmagnetic resonance imaging for the assessment of fibrosis inchronic hepatitis C. Hepatology 2007; 46: 658- 65 .
16. Koinuma M, Ohashi I, Hanafusa K, Shibuya H. Apparentdiffusion coefficient measurements with diffusion-weightedmagnetic resonance imaging for evaluation of hepatic fibrosis.J Magn Reson Imaging 2005;22: 80-85
17. Chang TT, Liaw YF, Wu SS, et al. Long-term entecavir therapyresults in the reversal of fibrosis/cirrhosis and continuedhistological improvement in patients with chronic hepatitis B.Hepatology 2010; 52: 886-893.
18. Kim JK, Ma DW, Lee KS, Paik YH. Assessment of hepaticfibrosis regression by transient elastography in patients withchronic hepatitis B treated with oral antiviral agents. J KoreanMed Sci 2014; 29: 570-5.
19. Hsu FO, Chiou YY, Chen CY, et al. Diffusion-weightedmagnetic resonance imaging of the liver in hepatitis B patientswith Child-Pugh a cirrhosis. Kaohsiung J Med Sci 2007; 23:442-6.
20. Pan Z, Meng F, Hu Y, Zhang X, Chen Y. Fat- and iron-correctedADC to assess liver fibrosis in patients with chronic hepatitis B.Diagn Interv Radiol 2022; 28: 5-11.
21. Fu F, Li X, Chen C, et al. Non-invasive assessment of hepaticfibrosis: comparison of MR elastography to transientelastography and intravoxel incoherent motion diffusion-weighted MRI. Abdom Radiol (NY) 2020; 45: 73-82.
22. Sheng RF, Jin KP, Yang L, et al. Histogram Analysis of DiffusionKurtosis Magnetic Resonance Imaging for Diagnosis of HepaticFibrosis. Korean J Radiol 2018; 19: 916-922.
23. Kromrey ML, Le Bihan D, Ichikawa S, Motosugi U. Diffusion-weighted MRI-based Virtual Elastography for the Assessmentof Liver Fibrosis. Radiology 2020; 295: 127-135.
24. Fu F, Li X, Liu Q, et al. Noninvasive DW-MRI metrics forstaging hepatic fibrosis and grading inflammatory activityinpatients with chronic hepatitis B. Abdom Radiol 2021; 46:1864-75.
25. Zheng Y, Xu YS, Liu Z, et al. Whole-liver apparent diffusioncoefficient histogram analysis for the diagnosis and staging ofliver fibrosis. J Magn Reson Imaging 2020; 51: 1745-54.
26. Jiang H, Chen J, Gao R, Huang Z, Wu M, Song B. Liver fibrosisstaging with diffusion-weighted imaging: a systematic reviewand meta-analysis. Abdom Radiol 2017; 42: 490-501.
Article available in :
Volume 6, Issue 2, 2023
Page : 282-288
https://doi.org/10.32322/jhsm.1211914
Article Information
Received : 29 Kas 2022
Accepted : 19 Oca 2023
Published : 27 Mar 2023
Corresponding Author :

Bora Aktaş: Department of Gastroenterology, Ankara Atatürk Sanatoryum Training and Research Hospital, Ankara, Turkey

[email protected]
Citation : Aktaş B, Aktaş E. The utility of apparent diffusion coefficient values in predicting liver fibrosis in chronic hepatitis B. J Health Sci Med 2023; 6(2): 282-288.

Read: 172
Cited: 0
Download : 140
_Footer